E. Parrotta

COVID-19 outcomes in MS

L. Krupp, L. Charvet, I. Kister, 2020, Neurology: Neuroimmunology & Neuroinflammation.

COVID-19 OUTCOMES IN MS: EARLY EXPERIENCE FROM NYU MULTIPLE SCLEROSIS COMPREHENSIVE CARE CENTER

L. Krupp, L. Charvet, I. Kister, 2020, medRxiv.

The Expanding Clinical Spectrum of Myelin Oligodendrocyte Glycoprotein (MOG) Antibody Associated Disease in Children and Adults

I. Kister, E. Parrotta, 2020, Frontiers in Neurology.

Multiple sclerosis risk factors contribute to onset heterogeneity.

D. Ontaneda, F. Briggs, D. Gunzler, 2019, Multiple sclerosis and related disorders.

It's not always an infection: Pyoderma gangrenosum of the urogenital tract in two patients with multiple sclerosis treated with rituximab.

L. Krupp, Lana Zhovtis Ryerson, E. Parrotta, 2022, Multiple sclerosis and related disorders.